allcancercure.com

Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race. It seems bacteria can operate in just the same way. Writing in the journal Nature, scientists from The University of Nottingham and The University of Edinburgh say bacteria have another trait that might [...]

Lyme disease in the U.S. is caused by a form of bacteria, the spirochete Borrelia burgdorferi, infecting humans by tick bites. It typically begins with a bull’s-eye skin rash, accompanied by fever, muscle aches, or other flu-like symptoms. If diagnosed early, Lyme can be treated successfully within a month with either oral or intravenous antibiotics. [...]

Measles deaths in Africa fell by 91 percent between 2000 and 2006, from an estimated 396,000 to 36,000, reaching the United Nations 2010 goal to cut measles deaths by 90 percent four years early. The spectacular gains achieved in Africa helped generate a strong decline in global measles deaths, which fell 68 percent worldwide — [...]

Testing by Ciba Specialty Chemicals in its laboratory in Basel, Switzerland has shown that Biosignal’s compounds have exceptional activity against micro-organisms. The work has been conducted under the joint development agreement signed between Biosignal and Ciba in March 2006. Completion of these studies marks progression to the next phase of the collaboration and triggers a [...]

Arpida Ltd (SWX: ARPN) announced the results of a Phase I trial investigating the possible interaction between intravenous iclaprim and warfarin. Warfarin is widely used for the prophylaxis of thrombosis and embolism and its dosing needs to be well-controlled.The drug-drug interaction study comprised 24 healthy volunteers and was performed in Germany. Dosing of warfarin with [...]

Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), has announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United [...]

The Health and Safety Executive (HSE) is publishing a report on its investigation into two outbreaks of Clostridium difficile (C. difficile) at Stoke Mandeville Hospital between 1 October 2003 and 30 June 2005. A copy of the report can be found at here. Launching the report Sandra Caldwell, HSE Director of Field Operations, said: ” [...]

Hadasit and Anadis, Ltd. (ASX:ANX) announced their intention to form a new joint venture company tentatively called Immuron. The mandate of the new company is to develop a new line of therapeutic products for the treatment of several inflammatory diseases, infectious diseases and cancers. The products will be based on a combination of intellectual property [...]